Sir-The Committee on Safety of Medicines is grateful for having been able to review, prior to publication, the recent paper by McPherson et al. (1987) .
This paper adds to the considerable body of knowledge which has now accumulated on this subject. At The CSM has considered the additional results now being made available in the light of all the current evidence. The Committee will continue to monitor the several studies which are still in progress on this subject but agrees with the view of McPherson et al. that the newly reported findings do not indicate the need to change at this time the current advice regarding the use of the presently available oral contraceptive agents. Thus, the Committee remains of the view that women receiving oral contraceptives should be prescribed a product with the lowest suitable content of both oestrogen and progestogen.
Yours etc., A.W. Asscher, Chairman, Committee on Safety of Medicines, Market Towers, 1 Nine Elms Lane, London SW8 5NQ
